Inhibition of myogenesis by notch: Evidence for multiple pathways

Journal of Cellular Physiology

Volumn 218, Issue 1, 2009, Pages 84-93

  Buas, Matthew F ^a   Kabak, Shara ^a   Kadesch, T O M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; MUSCLE PROTEIN; NOTCH RECEPTOR; PROTEIN HEY1; PROTEIN MYOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DLL4 PROTEIN, MOUSE; HEY1 PROTEIN, MOUSE; LIGAND; MEMBRANE PROTEIN; MSC PROTEIN, MOUSE; PRIMER DNA; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN TARGETING; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE; DNA PRIMERS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MEMBRANE PROTEINS; MICE; MODELS, BIOLOGICAL; MUSCLE DEVELOPMENT; MYOBLASTS, SKELETAL; RECEPTORS, NOTCH; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 58149145319     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21571     Document Type: Article

References (50)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284:770-776.
2. Atherton GT, Travers H, Deed R, Norton JD. 1996. Regulation of cell differentiation in C2CI2 myoblasts by the Id3 helix-loop-helix protein. Cell Growth Differ 7:1059-1066.
3. Cantini M, Massimino ML, Rapizzi E, Rossini K, Catani C, Dalla Libera L, Carraro U. 1995. Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. Biochem Biophys Res Commun 216:49-53.
4. Cheng TC, Wallace MC, Merlie JP, Olson EN. 1993. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 261:215-218.
5. Conboy IM, Rando TA. 2002. The regulation ofNotch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell 3:397-409.
6. Conboy IM, Conboy MJ, Smythe GM, Rando TA. 2003. Notch-mediated restoration of regenerative potential to aged muscle. Science 302:1575-1577.
7. Du K, Herzig S, Kulkarni RN, Montminy M. 2003. TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300:1574-1577.
8. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. 2004. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901-911.
9. Fischer A, Steidl C, Wagner TU, Lang E,Jakob PM, Friedl P, Knobeloch KP, Gessler M. 2007. Combined loss of HeyI and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res 100:856-863.
10. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M. 2005. Hypoxia requires notch signalingto maintain the undifferentiated cell state. Dev Cell 9:6I7-628.
11. Heron-Milhavet L, Mamaeva D, Rochat A, Lamb NJ, FernandezA. 2007. Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA. J Cell Physiol 214:158-165.
12. Ishitani T,MatsumotoK,Chitnis AB,Itoh M.2005.Nrarp functionsto modulateneural-crest-cell differentiation by regulating LEFI protein stability. Nat Cell Biol 7:1106-1112.
13. Iso T, Sartorelli V, Chung G, Shichinohe T, Kedes L, Hamamori Y. 2001. HERP, a new primary target of Notch regulated by ligand binding. Mol Cell Biol 21:6071-6079.
14. Iso T, Kedes L, Hamamori Y. 2003. HES and HERP families: Multiple effectors of the Notch signaling pathway. J Cell Physiol 194:237-255.
15. Kami K,SenbaE. 1998.Localization of leukemia inhibitory factor andinterleukin-6messenger ribonucleic acids in regenerating rat skeletal muscle. Muscle Nerve 21:819-822.
16. KawamataS,Du C,Li K,LavauC.2002.OverexpressionoftheNotch target genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene 21:3855-3863.
17. Keeshan K, He Y, Wouters BJ, Shestova O, Xu L, Sai H, Rodriguez CG, Maillard I, Tobias JW, Valk P, Carroll M, Aster JC, Delwel R, Pear WS. 2006. Tribbles homolog2 inactivates C/EBPalpha and causes acute myelogenous leukemia. Cancer Cell 10:401-411.
18. Kirschner M, Gerhart J. I998. Evolvability. Proc Natl Acad Sci USA 95:8420-8427.
19. Klinakis A, Szabolcs M, Politi K, Kiaris H, Artavanis-Tsakonas S, Efstratiadis A. 2006. Myc is a Notch I transcriptional target and a requisite for Notch I-induced mammary tumorigenesis in mice. Proc Natl Acad Sci USA 103:9262-9267.
20. Kopan R, Nye JS, Weintraub H. I994. The intracellular domain of mouse Notch: A constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of Myo D. Development 120:2385-2396.
21. Kuroda K, Tani S, Tamura K, Minoguchi S, Kurooka H, Honjo T. 1999. Delta-induced Notch signaling mediated by RBP-Jinhibits MyoD expression and myogenesis. J Biol Chem 274:7238-7244.
22. Lai EC. 2004. Notch signaling: Control of cell communication and cell fate. Development 131:965-973.
23. Lamar E,Deblandre G,Wettstein D,GawantkaV, Pollet N, Niehrs C, Kintner C. 2001. Nrarp is a novel intracellular component of the Notch signaling pathway. Genes Dev 15:1885-1899.
24. Lefort K, Dotto GP. 2004. Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. Semin Cancer Biol 14:374-386.
25. Lindsell CE, Shawber CJ, Boulter J, Weinmaster G. 1995. Jagged: A mammalian ligand that activates NotchI. Cell 80:909-917.
26. Louvi A, Artavanis-TsakonasS.2006.Notch signalling in vertebrate neural development. Nat Rev Neurosci 7:93-102.
27. Lu J, Webb R, Richardson JA, Olson EN. 1999. MyoR: Amuscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Proc Natl Acad Sci USA 96:552-557.
28. Lu JR,Bassel-Duby R, Hawkins A,Chang P,Valdez R, WuH, Gan L, Shelton JM, Richardson JA, Olson EN. 2002. Control of facial muscle development by MyoR and capsulin. Science 298:2378-2381.
29. Maillard I, Fang T, Pear WS. 2005. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 23:945-974.
30. Mammucari C, Tommasi di Vignano A, Sharov AA, Neilson J, Havrda MC, Roop DR, Botchkarev VA, Crabtree GR, Dotto GP. 2005. Integration of Notch I and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation control. Dev Cell 8:665-676.
31. Massari ME, Rivera RR, Voland JR, Quong MW, Breit TM, van Dongen JJ, de Smit O, Murre C. 1998. Characterization of ABF-I, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol Cell Biol 18:3130-3139.
32. Naiki T, Saijou E, Miyaoka Y, Sekine K, Miyajima A. 2007. TRB2, a mouse Tribbles ortholog, suppresses adipocyte differentiation by inhibiting AKT and C/EBPbeta. J Biol Chem 282:24075-24082.
33. Ohtsuka T, Ishibashi M,Gradwohl G, Nakanishi S, Guillemot F, Kageyama R.1999.Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J 18:2196-2207.
34. Pear WS, Nolan GP, Scott ML, Baltimore D. I993. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392-8396.
35. Reynaud-Deonauth S, Zhang H, Afouda A, Taillefert S, Beatus P, Kloc M, Etkin LD, Fischer-Lougheed J, Spohr G. 2002. Notch signaling is involved in the regulation of Id3 gene transcription during Xenopus embryogenesis. Differentiation 69:198-208.
36. Roca C, Adams RH. 2007. Regulation of vascular morphogenesis by Notch signaling. Genes Dev 21:2511-2524.
37. Ross DA, Rao PK, Kadesch T. 2004. Dual roles for the Notch target gene Hes-I in the differentiation of 3T3-LI preadipocytes. Mol Cell Biol 24:3505-3513.
38. Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S.1992.Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev 6:2620-2634.
39. Schuster-Gossler K, Cordes R, Gossler A. 2007. Premature myogenic differentiation and depletion of progenitor cells cause severe muscle hypotrophy in Delta I mutants. Proc Natl Acad Sci USA 104:537-542.
40. Shawber C, Nofziger D, Hsieh JJ, Lindsell C, Bogler O, Hayward D, Weinmaster G. 1996. Notch signaling inhibits muscle cell differentiation through a CBFI-independent pathway. Development 122:3765-3773.
41. Sun J, Kamei CN, Layne MD, Jain MK, Liao JK, Lee ME, Chin MT.2001.Regulation ofmyogenic terminal differentiation by the hairy-related transcription factor CHF2. J Biol Chem 276:18591-18596.
42. Varnum-Finney B, Wu L, Yu M, Brashem-Stein C, Staats S, Flowers D, Griffin JD, Bernstein ID. 2000. Immobilization of Notch ligand, Delta-I, is required for induction of notch signaling. J Cell Sci 113:4313-4318.
43. Vasyutina E, Lenhard DC, Wende H, Erdmann B, Epstein JA, Birchmeier C. 2007. RBP-J (Rbpsuh) is essential to maintain muscle progenitor cells and to generate satellite cells. Proc Natl Acad Sci USA 104:4443-4448.
44. Wang DZ, Valdez MR, Mc Anally J, Richardson J, Olson EN. 2001. The Mef2cgene is adirect transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development 128:4623-4633.
45. Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, Del Bianco C, Rodriguez CG, Sai H, Tobias J, Li Y, Wolfe MS, Shachaf C, Felsher D, Blacklow SC, Pear WS, Aster JC. 2006. c-Myc is an important direct target of NotchI in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 20:2096-2109.
46. Wilson A, Radtke F. 2006. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett 580:2860-2868.
47. Wilson EM, Rotwein P. 2007. Selective control of skeletal muscle differentiation by AktI. J Biol Chem 282:5106-5110.
48. Wilson-Rawls J, Molkentin JD, Black BL, Olson EN. 1999. Activated notch inhibits myogenic activityofthe MADS-Box transcription factor myocyte enhancer factor2C. Mol Cell Biol 19:2853-2862.
49. Zhao P, Hoffman EP. 2006. Musculin isoforms and repression of MyoD in muscle regeneration. Biochem Biophys Res Commun 342:835-842.
50. Zhu B, Ramachandran B,Gulick T.2005. Alternative pre-mRN Asplicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain. J Biol Chem 280:28749-28760.